Tradestie Institutional Equity Comparison Engine
BDMD vs DCTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BDMD counters with relative strength in Valuation. Fundamentally, BDMD trades at 0.7x Forward P/E with -58.5% operating margin (+24.6% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, BDMD sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BDMD
BDMD 0.7x vs DCTH N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin -58.5% vs 5.2% ยท YoY +24.6% vs +70.7%
Momentum & Technical Winner
DCTH
1Y -93.1% vs +128.6% ยท 52W Pos 0% vs 80%
Options & Structure Winner
DCTH
BREAKDOWN (N/A IV) vs BREAKOUT (43rd %ile IV)
BDMD
NASDAQ
Baird Medical Investment Holdings Ltd Ordinary Share
Surgical & Medical Instruments & Apparatus
$0.09
-2.54% 1D
Market Cap
$3.4M
1M Return
-84.42%
1Y Return
-93.11%
Forward P/E
0.7x
Unified AI Score
49.5 / 100
HOLD
Tech 60.0
Fund 58.0
Flow 50.0
Mom 65.0
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap
$743.8M
1M Return
+39.77%
1Y Return
+128.57%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 50.0
Fund 38.0
Flow 60.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BDMD -93.11%
DCTH +128.57%
Spread: +221.68 pp (DCTH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BDMD TTM Op. Margin: -58.5%
DCTH TTM Op. Margin: 5.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDMD vs DCTH. Trailing 12-month operating profitability (BDMD -58.5% vs DCTH 5.2%) and valuation multiples (BDMD 0.7x vs DCTH N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BDMD | DCTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.4M | $743.8M | Larger Scale | DCTH |
| Trailing P/E Ratio Valuation | 0.7x | 133.6x | Lower Multiple | BDMD |
| Forward P/E Ratio Valuation | 0.7x | N/M | Lower Multiple | BDMD |
| Revenue Growth (YoY) Growth | +24.6% | +70.7% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | -58.5% | 5.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | -65.1% | 6.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | -46.0% | 5.4% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 0% ($0โ$4) | 80% ($8โ$23) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 0.20ฮฒ ยท 302% Vol | 1.63ฮฒ ยท 131% Vol | Lower Realized Risk | DCTH |
| Unified Institutional Score Composite Signal | 49.5 / 100 (HOLD) | 35.9 / 100 (SELL) | Higher Composite | BDMD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BDMD vs DCTH Buy Guide
BDMD
BREAKDOWN
176d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DCTH
BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BDMD nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.